BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7541147)

  • 1. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
    Wollina U; Castelli E; Rülke D
    Recent Results Cancer Res; 1995; 139():303-16. PubMed ID: 7541147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of eccrine porocarcinoma.
    Wollina U; Castelli E
    Oncol Rep; 1994 Jan; 1(1):101-5. PubMed ID: 21607315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 protein expression in eccrine poroma and porocarcinoma.
    Akalin T; Sen S; Yücetürk A; Kandiloğlu G
    Am J Dermatopathol; 2001 Oct; 23(5):402-6. PubMed ID: 11801771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cytokeratin analysis of sweat gland ducts and eccrine poromas.
    Moll I; Moll R
    Arch Dermatol Res; 1991; 283(5):300-9. PubMed ID: 1718227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear-cell porocarcinoma in situ: a cytologic variant of porocarcinoma in situ.
    Rutten A; Requena L; Requena C
    Am J Dermatopathol; 2002 Feb; 24(1):67-71. PubMed ID: 11803286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New concepts on the histogenesis of eccrine neoplasia from keratin expression in the normal eccrine gland, syringoma and poroma.
    Langbein L; Cribier B; Schirmacher P; Praetzel-Wunder S; Peltre B; Schweizer J
    Br J Dermatol; 2008 Sep; 159(3):633-45. PubMed ID: 18647305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of hidroacanthoma simplex.
    Suh HS; Lee HJ; Kim HS; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 1997 Oct; 24(10):678-81. PubMed ID: 9375470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
    Tateyama H; Eimoto T; Tada T; Inagaki H; Nakamura T; Yamauchi R
    Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of eccrine poroma cells to cytokeratin 1- and 10-expressing cells, the intermediate layer cells of eccrine sweat duct, in the tumor cell nests.
    Ban M; Yoneda K; Kitajima Y
    J Cutan Pathol; 1997 Apr; 24(4):246-8. PubMed ID: 9138117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eccrine porocarcinoma (malignant eccrine poroma).
    Perna C; Cuevas J; Jiménez-Heffernan JA; Hardisson D; Contreras F
    Am J Surg Pathol; 2002 Feb; 26(2):272-4. PubMed ID: 11812953
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytokeratin expression of apocrine and eccrine poromas with special reference to its expression in cuticular cells.
    Yamamoto O; Hisaoka M; Yasuda H; Kasai T; Hashimoto H
    J Cutan Pathol; 2000 Aug; 27(7):367-73. PubMed ID: 10917164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
    Gu LH; Ichiki Y; Kitajima Y
    J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apocrine poroma of the breast.
    Azma A; Tawfik O; Casparian JM
    Breast J; 2001; 7(3):195-8. PubMed ID: 11469936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemically detectable duct-like structures in benign and malignant eccrine poromas: CEA and involucrin immunostaining.
    Tokura Y; Yoshikuni K; Teraki Y; Sugiura M; Takigawa M; Yamada M
    J Dermatol; 1989 Apr; 16(2):133-41. PubMed ID: 2550534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweat gland adenomas: immunohistochemical study with emphasis on myoepithelial differentiation.
    Wiley EL; Milchgrub S; Freeman RG; Kim ES
    J Cutan Pathol; 1993 Aug; 20(4):337-43. PubMed ID: 7693778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
    Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
    Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
    Russell-Goldman E; Hornick JL; Hanna J
    J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors.
    Eckert F; de Viragh PA; Schmid U
    J Cutan Pathol; 1994 Apr; 21(2):140-50. PubMed ID: 7518849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant poroma and porocarcinoma.
    Abarzúa Á; Álvarez-Véliz S; Moll-Manzur C
    An Bras Dermatol; 2017; 92(4):550-552. PubMed ID: 28954110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.